The molecular mechanisms underlying the development of cancer cachexia remain poorly defined, although tumor-derived catabolic factors such as activins, myostatin, and pro-inflammatory cytokines arising from tumor-immune system crosstalk are thought to contribute to its progression (3, 4). This evidence concerns the gene MSTN and neoplasm.